Overview

A Randomized Placebo Controlled Trial of the Effectiveness of Metformin in Addition to Usual Care in the Reduction of Gestational Diabetes Mellitus Effects

Status:
Recruiting

Trial end date:
2022-12-31

Target enrollment:

Participant gender:

Summary

The overall objective of the EMERGE trial is to determine whether metformin + usual care, compared to placebo + usual care (introduced at the time of initial diagnosis of GDM), reduces a) the need for insulin use, or hyperglycemia (primary outcome measure); b) excessive maternal weight gain; c) maternal and neonatal morbidities and, d) cost of treatment for women with Gestational Diabetes Mellitus.

Phase:

Phase 3

Details

Lead Sponsor:

National University of Ireland, Galway, Ireland

Collaborators:

Cork University Hospital
Health Research Board, Ireland
HRB Clinical Research Facility Galway, Ireland
Portiuncula University Hospital
University College Hospital Galway

Treatments:

Metformin